Diabetes impacts over 37.3 million individuals, with nearly 96 million more facing pre-Diabetes. The condition poses a heightened risk for severe health complications, including cardiovascular issues, eye problems, kidney disease, nerve damage, and dental issues, all exacerbated by consistently high blood glucose levels. Furthermore, diabetes increases susceptibility to infections and is a leading cause of cardiovascular disease, blindness, kidney failure, and lower limb amputation.
Hyperbaric Therapy (HBOT) has emerged as a promising intervention to address these complications. By stimulating angiogenesis, HBOT aids in restoring compromised blood flow and preventing organ failure. Studies suggest that it can regulate blood sugar levels by enhancing cellular sensitivity to insulin and facilitating skeletal muscle glucose reception. Recent findings even hint at HBOT’s potential to boost insulin production. Beyond glycemic control, HBOT proves beneficial in treating conditions like Osteomyelitis and Cellulitis, while also safeguarding against systemic toxicity and permanent damage.
Chronic diabetes often leads to impaired circulation, hampering wound healing and resulting in ulcerations. HBOT steps in by augmenting oxygen levels in ulcerated areas, thereby activating fibroblasts and fostering healing processes.
- Enhanced Blood Chemistry Profile: Monitors fasting blood sugar, Hemoglobin HbA1C, and lipid levels.
- Improved Glycemic Control: Increases insulin sensitivity and skeletal muscle glucose reception.
- Reduced Cardiovascular Risk: Promotes long-term blood pressure control, mitigates metabolic syndrome, and lowers the risk of sudden heart attacks due to ventricular arrhythmias.
- Stimulated Angiogenesis and Reduced Inflammation: Combats cellulitis, diminishes the risk of diabetic neuropathy, enhances heart function, reduces stroke risk, and minimizes the risk of diabetic retinopathy.
- Enhanced Healing: Alleviates ulcerations, fosters epithelialization, facilitates closure of non-healing wounds and reduces the risk of amputation.
Diabetes Studies
- HBOT and Wounds in Diabetes: https://www.ihausa.org/pdf/adult-indications/diabetes/hbot-and-wounds-in-diabetes.pdf
- HBOT Combined with Platelet-Rich Plasma on Diabetic Wounds: https://www.ihausa.org/pdf/adult-indications/diabetes/hbot-combined-with-platelet-rich-plasma-on-diabetic-wounds.pdf
- HBOT for Diabetics: https://www.ihausa.org/pdf/adult-indications/diabetes/hbot-for-diabetics.pdf
- HBOT Helps Lower Blood Sugar: https://www.ihausa.org/pdf/adult-indications/diabetes/hbot-helps-lower-blood-sugar.pdf
- Managing Obesity and Metabolic Syndrome with HBOT: https://www.ihausa.org/pdf/adult-indications/diabetes/managing-obesity-and-metabolic-syndrome-with-hbot.pdf
- Mild Hyperbaric Oxygen Inhibits Growth-Related Decrease in Muscle Oxidative Capacity: https://www.ihausa.org/pdf/adult-indications/diabetes/mild-hyperbaric-oxygen-inhibits-growth-related-decrease-in-muscle-oxidative-capacity.pdf
- The Effect of Hyperbaric Therapy on Brown Adipose Tissue: https://www.ihausa.org/pdf/adult-indications/diabetes/the-effect-of-hyperbaric-therapy-on-brown-adipose-tissue.pdf
